From
Dr. Alberto Tozzi
The FLURESP European commission project: cost-effectiveness assessment of ten public health measures against influenza in Italy: is there an interest in COVID-19 pandemic?
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · May 2023 · 1 min read
In brief
In brief
European study evaluating cost-effectiveness of ten public health interventions against influenza pandemics within the Italian healthcare system, with applicability to COVID-19. Findings indicate reducing secondary infections and expanding ICU life support equipment are most cost-effective strategies for mortality reduction, while screening interventions show least value across pandemic severity levels.
Written by the GCMD Library team from the article.
Background: The FLURESP project is a public health research funded by the European Commission, with the objective to design a methodological framework to assess the cost-effectiveness of existing public health measures against human influenza pandemics. A dataset has been specifically collected in the frame of the Italian health system. As most of interventions against human influenza are relavant against other respiratory diseases pandemics, potential interests in COVID-19 are discussed. Methods: Ten public health measures against human influenza pandemics pandemic were selected to be also relevant to other respiratory virus pandemics such as COVID 19: individual (hand washing, using masks), border control (quarantine, fever screening, border closure), community infection (school closure, class dismissal, social distancing, limitation of public transport), reduction of secondary infections (implementation of antibiotic therapy guidelines), pneumococcal vaccination for at-risk people, development of Intensive Care Unit (ICU) capacity, implementation of life support equipments in ICU, screening interventions, vaccination programs targeting health professional and targeting general population. Results: Using mortality reduction as effectiveness criteria, the most cost-effective strategies are "reduction of secondary infections" and "implementation of life support equipment in ICU". The least cost-effective option whatever the level of pandemic events are screening interventions
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Podcast
Le funzioni e gli usi dell'intelligenza artificiale per la salute
Alberto Tozzi · 14 min · Published Oct 2026
Article
Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
Alberto Tozzi · Published Oct 2026
Podcast
Data to impact: connecting the future of European pediatrics with Alberto Tozzi
Alberto Tozzi · 20 min · Published Oct 2026
Article
[Obesity and cardiovascular risk in children].
Alberto Tozzi · Published Oct 2026
Article
Towards learning healthcare systems in Italy: opportunities and challenges of AI at point-of-care.
Alberto Tozzi · Published Oct 2026
Article
Methicillin-resistant Staphylococcus aureus nasal colonization in a department of pediatrics: a cross-sectional study.
Alberto Tozzi · Published Oct 2026
